REFERENCES
- Lamb S, Merwyn RG, McCarty D. Bridging the Gap Between Practice and Research: Forging Partnerships With Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press, 1998.
- Tai B, Straus MM, Liu D, Sparenborg S, Jackson R, McCarty D. The first decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the gap between research and practice to improve drug abuse treatment. J Subst Abuse Treat 2010; 38(Suppl. 1):S4–13.
- CISCRP, Clinical trial facts and figures for health professionals. Available at http://www.ciscrp.org/professional/facts_graphs.html. Last accessed on May 22, 2010.
- Hohmann AA, Shear MK. Community-based intervention research: Coping with the “noise” of real life in study design. Am J Psychiatry 2002; 159(2):201–207.
- Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T. Bringing buprenorphine-naloxone detoxification to community treatment providers: The NIDA Clinical Trials Network field experience. Am J Addict 2004; 13(Suppl. 1):S42–S66.
- Wright JT, Jr, Cushman WC, Davis BR, Barzilay J, Colon P, Egan D, Lucente T, Mwachuku C, Pressel S, Leenen FH, Frolkis J, Letterer R, Walsh S, Tobin JN, Deger GE, ALLHAT Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Clinical center recruitment experience. Control Clin Trials 2001; 22(6):659–673.
- Maggon K. Investigator and site selection and performing GCP clinical studies in India. Control Clin Trials 2004; 25(4):366–377.
- Zweben A, Donovan DM, Randall CL, Barrett D, Dermen K, Kabela E, McRee B, Meyers R, Rice C, Rosengren D, Schmidt P, Snow M, Thevos AK, Velasquez M. Issues in the development of subject recruitment strategies and eligibility criteria in multisite trials of matching. J Stud Alcohol Suppl 1994; 12:62–69.
- Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology. Contemp Clin Trials 2010; 31(2):189–199.
- Donovan D. Stimulant Abuser Groups to engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement. Available at http://ctndisseminationlibrary.org/protocols/ctn0031.htm. Last accessed on February 17, 2011.
- Simpson DD. A conceptual framework for transferring research to practice. J Subst Abuse Treat 2002; 22(4):171–182.
- McCarty D, Fuller BE, Arfken C, Miller M, Nunes EV, Edmundson E, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, opinions, and beliefs. Psychiatr Serv 2007; 58(2):181–190.
- Forman RF, Bovasso G, Woody G, McNicholas L, Clark C, Royer-Malvestuto C, Weinstein S. Staff beliefs about drug abuse clinical trials. J Subst Abuse Treat 2002; 23(1):55–60.
- Knudsen HK, Ducharme LJ, Roman PM. Research participation and turnover intention: An exploratory analysis of substance abuse counselors. J Subst Abuse Treat 2007; 33(2):211–217.
- Wakim P, . Relation of study design on recruitment and retention. Am J Drug Alcohol Abuse 2011; 37(5):431–438.